Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia D Suerth

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 16, 2012
Alpharetroviral self-inactivating vectors: long-term transgene expression in murine hematopoietic cells and low genotoxicityJulia D Suerth, Tobias Maetzig, Martijn H Brugman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 4, 2016
Generation of Genetically Engineered Precursor T-Cells From Human Umbilical Cord Blood Using an Optimized Alpharetroviral Vector PlatformJuwita Hübner, Shahabuddin S Hoseini, Julia D Suerth, et al.
Molecular Therapy. Nucleic Acids|February 10, 2022
Improved alpharetrovirus-based Gag.MS2 particles for efficient and transient delivery of CRISPR-Cas9 into target cellsYvonne Baron, Johanna Sens, Lucas Lange, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 16, 2012
Alpharetroviral self-inactivating vectors: long-term transgene expression in murine hematopoietic cells and low genotoxicityJulia D Suerth, Tobias Maetzig, Martijn H Brugman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 4, 2016
Generation of Genetically Engineered Precursor T-Cells From Human Umbilical Cord Blood Using an Optimized Alpharetroviral Vector PlatformJuwita Hübner, Shahabuddin S Hoseini, Julia D Suerth, et al.
Molecular Therapy. Nucleic Acids|February 10, 2022
Improved alpharetrovirus-based Gag.MS2 particles for efficient and transient delivery of CRISPR-Cas9 into target cellsYvonne Baron, Johanna Sens, Lucas Lange, et al.
Pageof 2